Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial - Concepedia

Concepedia

Publication | Open Access

Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial

DOI Full Paper Access

17

Citations

26

References

2022

Year

Bradford S. Hoppe, R.C. Nichols, Stella Flampouri, Mark Pankuch, Christopher G. Morris, Dat C. Pham, Pranshu Mohindra, William F. Hartsell, Nasiruddin Mohammed, Brian Chon,

International Journal of Radiation Oncology*Biology*Physics

Abstract

Hypofractionated proton therapy delivered at 2.5 to 3.53 Gy per fraction to a total 60 Gy with concurrent chemotherapy provides promising survival, and additional examination through larger studies may be warranted.

References

	Year	Citations

Page 1